FDA approves drug for tough-to-treat type of leukemia

TRENTON, N.J. (AP) — The U.S. Food and Drug Administration has approved a new drug targeting a subset of leukemia patients with a genetic abnormality that makes the cancer harder to treat.

Patients can get financial assistance reducing copayments to as low as $25.